Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.clinicaltrialsarena.com/news/cardiol-recurrent-pericarditis-trial/
https://www.biospace.com/article/cardiol-therapeutics-announces-pre-clinical-study-results-demonstrating-cardiolrx-tm-inhibits-and-also-promotes-reversal-of-mechanisms-leading-to-cardiac-fibrosis/
https://www.newswire.ca/news-releases/cardiol-therapeutics-files-preliminary-prospectus-supplement-for-proposed-public-offering-of-units-876229890.html
https://www.cardiolrx.com/cardiol-therapeutics-expands-lancer-phase-ii-iii-trial-cardiolrx/
https://www.cardiolrx.com/cardiol-therapeutics-receives-fda-ind-application-acute-myocarditis/
https://www.cardiolrx.com/cardiol-therapeutics-announces-first-patient-enrolled-in-lancer-a-phase-ii-iii-outcomes-trial-in-high-risk-patients-hospitalized-with-covid-19/
https://www.proactiveinvestors.com/companies/news/946297/cardiol-therapeutics-says-cardiolrx-safe-and-well-tolerated-in-phase-i-study-of-oral-cannabidiol-formulation-946297.html